The importance of jumping ability in basketball is well known, but there is an evident lack of studies that have examined different jumping testing protocols in basketball players at advanced levels. The aim of this study was to assess the applicability of different tests of jumping capacity in identifying differences between (i) playing position and (ii) competitive levels of professional players. Participants were 110 male professional basketball players (height: 194.92±8.09 cm; body mass: 89.33±10.91 kg; 21.58±3.92 years of age; Guards, 49; Forwards, 22; Centres, 39) who competed in the first (n = 58) and second division (n = 52). The variables included anthropometrics and jumping test performance. Jumping performances were evaluated by the standing broad jump (SBJ), countermovement jump (CMJ), reactive strength index (RSI), repeated reactive strength ability (RRSA) and four running vertical jumps: maximal jump with (i) take-off from the dominant leg and (ii) non-dominant leg, lay-up shot jump with take-off from the (iii) dominant leg and (iv) non-dominant leg. First-division players were taller (ES: 0.76, 95%CI: 0.35-1.16, moderate differences), heavier (0.69, 0.29-1.10), had higher maximal reach height (0.67, 0.26-1.07, moderate differences), and had lower body fat % (-0.87, -1.27-0.45, moderate differences) than second-division players. The playing positions differed significantly in three of four running jump achievements, RSI and RRSA, with Centres being least successful. The first-division players were superior to second-division players in SBJ (0.63, 0.23-1.03; 0.87, 0.26-1.43; 0.76, 0.11-1.63, all moderate differences, for total sample, Guards, and Forwards, respectively). Running vertical jumps and repeated jumping capacity can be used as valid measures of position-specific jumping ability in basketball. The differences between playing levels in vertical jumping achievement can be observed by assessing vertical jump scores together with differences in anthropometric indices between levels.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5676323 | PMC |
http://dx.doi.org/10.5114/biolsport.2017.67122 | DOI Listing |
ACR Open Rheumatol
January 2025
Hospital for Special Surgery and Weill Cornell Medicine, New York City, New York.
Objective: Fatigue is important for patients with rheumatoid arthritis (RA) but is poorly understood. We sought to study associations of fatigue with clinical features, disease activity, and synovial histology.
Methods: Patients meeting the American College of Rheumatology/EULAR 1987 and/or 2010 RA criteria were recruited before elective total joint replacement.
Epidemiol Psychiatr Sci
January 2025
Department of Global Public Health, Karolinska Institute, Stockholm, Sweden.
Aims: Although individuals with lower socio-economic position (SEP) have a higher prevalence of mental health problems than others, there is no conclusive evidence on whether mental healthcare (MHC) is provided equitably. We investigated inequalities in MHC use among adults in Stockholm County (Sweden), and whether inequalities were moderated by self-reported psychological distress.
Methods: MHC use was examined in 31,433 individuals aged 18-64 years over a 6-month follow-up period, after responding to the General Health Questionnaire-12 (GHQ-12) in 2014 or the Kessler Six (K6) in 2021.
Front Pharmacol
January 2025
State Key Laboratory of Medicinal Chemical Biology, College of Pharmacy and Tianjin Key Laboratory of Molecular Drug Research, Nankai University, Tianjin, China.
Introduction: Deglycosylated azithromycin (Deg-AZM), a new transgelin agonist with positive therapeutic effects on slow transit constipation, has been approved for clinical trials in 2024. This work investigated the drug metabolism and transport of Deg-AZM to provide research data for further development of Deg-AZM.
Methods: A combination of UPLC-QTOF-MS was used to obtain metabolite spectra of Deg-AZM in plasma, urine, feces and bile.
Brain Commun
January 2025
Institute for Stroke and Dementia Research, University Hospital, Ludwig Maximilian University of Munich, Munich 81377, Germany.
Traumatic brain injury is widely viewed as a risk factor for dementia, but the biological mechanisms underlying this association are still unclear. In previous studies, traumatic brain injury has been associated with the hallmark pathologies of Alzheimer's disease, i.e.
View Article and Find Full Text PDFBrain Commun
January 2025
Department of Clinical Medicine, Aarhus University Hospital, Aarhus N, 8200 Aarhus, Denmark.
Asymmetric dopaminergic degeneration of the striatum is a characteristic feature of Parkinson's disease, associated with right-left asymmetry in motor function. As such, studying asymmetry provides insights into progressive neurodegeneration between cerebral hemispheres. Given the impact of Lewy pathology on various neurotransmitter systems beyond the dopaminergic, it may be that other neuronal systems in the predominantly affected hemisphere are similarly affected.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!